| Q48638122 | A glutamate antagonist blocks perforant path stimulation-induced reduction of dynorphin peptide and prodynorphin mRNA levels in rat hippocampus |
| Q46505921 | Adenylate cyclase-mediated forms of neuronal plasticity in hippocampal area CA1 are reduced with aging |
| Q34486574 | Age- and hormone-regulation of opioid peptides and synaptic proteins in the rat dorsal hippocampal formation. |
| Q36709707 | Age-associated changes in hippocampal-dependent cognition in Diversity Outbred mice |
| Q43086100 | Age-related changes in conditioned flavor preference in rats |
| Q48623007 | Age-related changes in galanin-immunoreactive cells of the rat medial septal area |
| Q48253449 | Alterations in [3H]-kainate receptor binding in the hippocampal formation of aged Long-Evans rats |
| Q56442716 | Applications of the Morris water maze in the study of learning and memory |
| Q37893567 | Calcium signaling in cognition and aging-dependent cognitive decline |
| Q44582206 | Decreased glutamate release correlates with elevated dynorphin content in the hippocampus of aged rats with spatial learning deficits |
| Q42471669 | Different modulation of cholinergic neuronal systems by dynorphin A (1-13) in carbon monoxide-exposed mice |
| Q55452280 | Downregulation of the neuronal opioid gene expression concomitantly with neuronal decline in dorsolateral prefrontal cortex of human alcoholics. |
| Q52045378 | Effects of dynorphin A (1-13) on carbon monoxide-induced delayed amnesia in mice. |
| Q52178727 | Effects of nocistatin on nociceptin-induced impairment of learning and memory in mice. |
| Q28533990 | Effects of rearing conditions on behaviour and endogenous opioids in rats with alcohol access during adolescence |
| Q36174208 | Endogenous dynorphins inhibit excitatory neurotransmission and block LTP induction in the hippocampus. |
| Q41191019 | Endogenous opioid regulation of hippocampal function |
| Q48351465 | Expression of BDNF and trkB as a function of age and cognitive performance |
| Q47727467 | Gene polymorphisms in prodynorphin (PDYN) are associated with episodic memory in the elderly |
| Q44349020 | Hippocampal dynorphin B injections impair spatial learning in rats: a kappa-opioid receptor-mediated effect |
| Q48150837 | Hippocampal gene expression profiling reveals the possible involvement of Homer1 and GABA(B) receptors in scopolamine-induced amnesia. |
| Q41868977 | Improvement by dynorphin A (1-13) of galanin-induced impairment of memory accompanied by blockade of reductions in acetylcholine release in rats |
| Q47864266 | Knockdown of prodynorphin gene prevents cognitive decline, reduces anxiety, and rescues loss of group 1 metabotropic glutamate receptor function in aging. |
| Q71859464 | L-type calcium channels mediate dynorphin neuropeptide release from dendrites but not axons of hippocampal granule cells |
| Q36824990 | Memory-enhancing effect of aspirin is mediated through opioid system modulation in an AlCl3-induced neurotoxicity mouse model |
| Q28343438 | Nociceptin/orphanin FQ and nocistatin on learning and memory impairment induced by scopolamine in mice |
| Q57498472 | Opioid modulation of cognitive impairment in depression |
| Q52031341 | Peptide immunoreactivity in aged rat cortex and hippocampus as a function of memory and BDNF infusion. |
| Q36081754 | Prodynorphin CpG-SNPs associated with alcohol dependence: elevated methylation in the brain of human alcoholics |
| Q33938940 | Prominent hippocampal CA3 gene expression profile in neurocognitive aging |
| Q48664529 | Recognition memory deficits in a subpopulation of aged monkeys resemble the effects of medial temporal lobe damage |
| Q42587373 | Reversion of muscarinic autoreceptor agonist-induced acetylcholine decrease and learning impairment by dynorphin A (1-13), an endogenous kappa-opioid receptor agonist |
| Q38482054 | Signaling pathways relevant to cognition-enhancing drug targets. |
| Q36879616 | Spatial behavior and seizure-induced changes in c-fos mRNA expression in young and old rats |
| Q71720227 | Spatial learning in deer mice: sex differences and the effects of endogenous opioids and 60 Hz magnetic fields |
| Q36092808 | Targeting dynorphin/kappa opioid receptor systems to treat alcohol abuse and dependence |
| Q37589122 | The dynorphin/kappa opioid system as a modulator of stress-induced and pro-addictive behaviors |
| Q37946259 | The dynorphin/κ-opioid receptor system and its role in psychiatric disorders |
| Q43986601 | The endogenous opioid system in human alcoholics: molecular adaptations in brain areas involved in cognitive control of addiction |
| Q42435029 | The regulation of hippocampal dynorphin by neural/neuroendocrine pathways: models for effects of aging on an opioid peptide system |
| Q37141232 | The role of calsenilin/DREAM/KChIP3 in contextual fear conditioning |
| Q44347548 | U-50,488H, a selective kappa opioid receptor agonist, ameliorates memory impairments induced by muscarinic autoreceptor agonist, carbachol in mice |
| Q52052324 | Ultrastructural heterogeneity of enkephalin-containing terminals in the rat hippocampal formation. |
| Q37281169 | Upregulated dynorphin opioid peptides mediate alcohol-induced learning and memory impairment |